Denali Therapeutics (DNLI) EBITDA Margin Growth (3y) (2021 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -932.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,003.00
10 Denali Therapeutics 3.82 Bn 3.82 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 116.76 Mn
Jun 30, 2023 107,250.00
Mar 31, 2023 10.79 Mn
Dec 31, 2022 29,915.00
Sep 30, 2022 -739,425.00
Jun 30, 2022 5.83 Mn
Mar 31, 2022 73,316.00
Dec 31, 2021 -67,955.00
Sep 30, 2021 135,005.00
Jun 30, 2021 292,762.00
Mar 31, 2021 -699.90 Mn